Covaxin Phase 2, 3 Clinical Trials for 2-18 Age Group Get Green Signal from DCGI
New Delhi: The Drug Controller General of India (DGCI) on Thursday gave permission to Bharat Biotech to conduct clinical trials of its Covid-19 vaccines Covaxin on children belonging to the age group of 2 to 18 years.
Bharat Biotech…
Read More...
Read More...